Published in Onco Targets Ther on February 20, 2017
Cancer statistics, 2013. CA Cancer J Clin (2013) 84.72
The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol (2010) 24.32
THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. Acta Pathol Microbiol Scand (1965) 22.65
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med (2001) 18.77
Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat Rev Cancer (2005) 9.04
Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer (2013) 6.13
Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology (2004) 2.66
Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget. Oncotarget (2010) 1.88
Anoikis: cancer and the homeless cell. Nature (2004) 1.54
Impact of the 7th Edition AJCC staging classification on the NCCN clinical practice guidelines in oncology for gastric and esophageal cancers. J Natl Compr Canc Netw (2013) 1.35
[WHO Classification of digestive tumors: the fourth edition]. Ann Pathol (2011) 1.34
Tumor budding in colorectal carcinoma: time to take notice. Mod Pathol (2012) 1.32
Tumor budding as a strong prognostic indicator in invasive ampullary adenocarcinomas. Am J Surg Pathol (2010) 1.13
Tumor budding correlates with poor prognosis and epithelial-mesenchymal transition in tongue squamous cell carcinoma. J Oral Pathol Med (2011) 1.08
Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Radiother Oncol (2014) 1.05
Tumour budding and a low host inflammatory response are associated with a poor prognosis in oesophageal and gastro-oesophageal junction cancers. Histopathology (2010) 1.05
Gastric adenocarcinoma: pathomorphology and molecular pathology. J Cancer Res Clin Oncol (2001) 1.02
Tumor budding as a prognostic marker in laryngeal carcinoma. Pathol Res Pract (2009) 0.98
Histopathologic features of the tumor budding in adenocarcinoma of the lung: tumor budding as an index to predict the potential aggressiveness. J Thorac Oncol (2010) 0.98
Tumor budding is an independent adverse prognostic factor in pancreatic ductal adenocarcinoma. Am J Surg Pathol (2015) 0.91
Triclosan potentiates epithelial-to-mesenchymal transition in anoikis-resistant human lung cancer cells. PLoS One (2014) 0.87
European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Annotations of colorectal lesions. Endoscopy (2012) 0.85
Tumor budding in upper gastrointestinal carcinomas. Front Oncol (2014) 0.84
Regulated genes in mesenchymal stem cells and gastric cancer. World J Stem Cells (2015) 0.81
Clinicopathological characteristics and treatment strategies in early gastric cancer: a retrospective cohort study. J Exp Clin Cancer Res (2011) 0.81
NCCN practice guidelines for upper gastrointestinal carcinomas. National Comprehensive Cancer Network. Oncology (Williston Park) (1998) 0.81
Invasion Types Are Associated With Poor Prognosis in Lung Squamous Carcinoma Patients. Medicine (Baltimore) (2015) 0.79
Prognostic and predictive factors in gingivo buccal complex squamous cell carcinoma: role of tumor budding and pattern of invasion. Indian J Otolaryngol Head Neck Surg (2014) 0.78
Goseki grade and tumour location influence survival of patients with gastric cancer. Asian Pac J Cancer Prev (2014) 0.77